Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 10—October 2024
Dispatch

Oxacillinase-484–Producing Enterobacterales, France, 2018–2023

Cécile Emeraud, Sandrine Bernabeu, Delphine Girlich, Inès Rezzoug, Agnès B. Jousset, Aurélien Birer, Thierry Naas, Rémy A. Bonnin, and Laurent DortetComments to Author 
Author affiliations: Bicêtre Hospital, Le Kremlin-Bicetre, France (C. Emeraud, S. Bernabeu, I. Rezzoug, A.B. Jousset, T. Naas, R.A. Bonnin, L. Dortet); INSERM, Paris, France (D. Girlich); Centre National de Référence de la Résistance aux Antibiotiques, Clermont-Ferrand, France (A. Birer)

Main Article

Figure 1

Evolution of number of OXA-484–producing CPE isolates received at the French National Reference Center for Carbapenem-Resistant Enterobacterales, France, 2012–2023. No OXA-484–producing isolate was received before 2018. Colors indicate species and STs. CPE, carbapenem-resistant Enterobacterales; OXA, oxacillinase; ST, sequence type.

Figure 1. Evolution of number of OXA-484–producing CPE isolates received at the French National Reference Center for Carbapenem-Resistant Enterobacterales, France, 2012–2023. No OXA-484–producing isolate was received before 2018. Colors indicate species and STs. CPE, carbapenem-resistant Enterobacterales; OXA, oxacillinase; ST, sequence type.

Main Article

Page created: August 14, 2024
Page updated: September 23, 2024
Page reviewed: September 23, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external